Tag: pharmaceutical M&A Brazil

Insights

EMS to Buy Medley for $600 Million, Deal Set to Face Cade Scrutiny

6 de March de 2026

The most comprehensive resource for portfolio managers and investors focused on emerging markets — with a special emphasis on Brazil. In-depth analysis, curated insights, and data-driven perspectives on Latin America’s largest economy.

Navigate

Home
About us
Insights
Compliance
Contact

Follow

X
Instagram
LinkedIn
Facebook

Tag: pharmaceutical M&A Brazil

EMS to Buy Medley for $600 Million, Deal Set to Face Cade Scrutiny